NCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
Clinical Trials
105 trialsNCT05607017 2026-04-06
Losartan in Prevention of Radiation-Induced Heart Failure
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT04721886 2026-04-02
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT01881048 2026-01-29
Window of Opportunity Study Targeting the Inflammatory Milieu
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT06499090 2026-01-22
Mirtazapine for Acute and Chronic Post Mastectomy Pain
Assiut University
Phase EARLY_PHASE1 Completed
NCT04821375 2025-10-29
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT03802604 2025-09-09
PROMETEO
SOLTI Breast Cancer Research Group
Phase EARLY_PHASE1 Completed
NCT06273852 2025-08-11
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Pure Biologics S.A.
Phase EARLY_PHASE1 Completed
NCT05859971 2025-07-29
ICG and SLN Mapping
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT03685175 2025-03-30
HPCardiotox
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Completed
NCT06760429 2025-01-06
Comparative Evaluation of Pectoral Nerve Block Type II Versus Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Mastectomy for Postoperative Analgesia: a Randomized, Controlled Trial
Inner Mongolia Baogang Hospital
Phase EARLY_PHASE1 Completed
NCT04674722 2024-12-09
HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Completed
NCT03629717 2024-10-16
RANKL Inhibition and Breast Tissue Biomarkers
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT03962647 2024-10-15
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Completed
NCT03911453 2024-10-03
Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
University of Arizona
Phase EARLY_PHASE1 Completed
NCT04481230 2024-10-01
CARSPECT
Centre Jean Perrin
Phase EARLY_PHASE1 Completed
NCT02913430 2024-09-23
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT02415387 2024-07-24
IMPACT
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT03542695 2024-06-24
64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy
City of Hope Medical Center
Phase EARLY_PHASE1 Completed
NCT04925817 2024-06-07
3D Ultrasound Microvessel Imaging for Breast Masses
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03132467 2024-06-05
Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT04752267 2024-05-24
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
University of Southern California
Phase EARLY_PHASE1 Completed
NCT05331807 2024-05-08
Omega-3 and Vitamin D Supplementation in Breast Cancer Women
Universiti Sains Malaysia
Phase EARLY_PHASE1 Completed
NCT06090630 2024-04-17
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01916122 2024-04-05
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT03564782 2024-02-08
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer
Istari Oncology, Inc.
Phase EARLY_PHASE1 Completed
NCT01383135 2024-01-12
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Stanford University
Phase EARLY_PHASE1 Completed
NCT03928210 2023-12-13
Digoxin Induced Dissolution of CTC Clusters
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Completed
NCT04341129 2023-12-05
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
University of Chicago
Phase EARLY_PHASE1 Completed
NCT01074814 2023-09-28
Side-Out
Translational Drug Development
Phase EARLY_PHASE1 Completed
NCT01980823 2023-08-30
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Columbia University
Phase EARLY_PHASE1 Completed
NCT03599453 2023-07-18
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT02538484 2023-07-17
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT03122444 2023-06-28
Imipramine on ER+ve and Triple Negative Breast Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT04040686 2023-04-14
HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Completed
NCT04041128 2023-03-20
PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Completed
NCT03411070 2023-01-17
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT03407716 2023-01-05
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02013492 2022-12-06
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT04797728 2022-10-26
ELIPSE
SOLTI Breast Cancer Research Group
Phase EARLY_PHASE1 Completed
NCT04130152 2022-10-25
PROMETEO II
SOLTI Breast Cancer Research Group
Phase EARLY_PHASE1 Completed
NCT02065609 2022-10-13
89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT04267900 2022-09-14
99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Completed
NCT04019834 2022-08-03
RELIEF
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT04142892 2022-04-01
ONAWA
SOLTI Breast Cancer Research Group
Phase EARLY_PHASE1 Completed
NCT02517502 2022-01-24
Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT03954015 2022-01-10
Comparison of Three Methods for Early Detection of Breast Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT03197389 2021-05-19
Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.
Universitaire Ziekenhuizen KU Leuven
Phase EARLY_PHASE1 Completed
NCT03661892 2021-04-29
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets
University of Arizona
Phase EARLY_PHASE1 Completed